These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma. Tan K; Lu W; Chen F; Shi H; Ma Y; Chen Z; Wu W; Lv Z; Mo J J Exp Clin Cancer Res; 2023 Sep; 42(1):250. PubMed ID: 37759224 [TBL] [Abstract][Full Text] [Related]
24. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522 [TBL] [Abstract][Full Text] [Related]
34. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation. Sgouras DN; Athanasiou MA; Beal GJ; Fisher RJ; Blair DG; Mavrothalassitis GJ EMBO J; 1995 Oct; 14(19):4781-93. PubMed ID: 7588608 [TBL] [Abstract][Full Text] [Related]
35. Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53. van der Ent W; Jochemsen AG; Teunisse AF; Krens SF; Szuhai K; Spaink HP; Hogendoorn PC; Snaar-Jagalska BE J Pathol; 2014 Aug; 233(4):415-24. PubMed ID: 24974828 [TBL] [Abstract][Full Text] [Related]
36. Epigenetic and Transcriptional Signaling in Ewing Sarcoma-Disease Etiology and Therapeutic Opportunities. Li M; Chen CW Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740349 [TBL] [Abstract][Full Text] [Related]
37. EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival. Gallegos ZR; Taus P; Gibbs ZA; McGlynn K; Gomez NC; Davis I; Whitehurst AW Mol Cell Biol; 2019 Jul; 39(14):. PubMed ID: 31036566 [TBL] [Abstract][Full Text] [Related]
38. Primary intracranial Ewing sarcoma/ peripheral primitive neuroectodermal tumor, an entity of unacquaintance: a series of 8 cases. Deshpande G; Epari S; Gupta C; Shetty O; Gurav M; Chinnaswamy G; Moiyadi A; Gupta T Childs Nerv Syst; 2021 Mar; 37(3):839-849. PubMed ID: 32761378 [TBL] [Abstract][Full Text] [Related]
39. The prognostic signature of the somatic mutations in Ewing sarcoma: from a network view. Zhang Y; Song J; Shi Q; Song X; Shen L; Zhou J; Shao J Jpn J Clin Oncol; 2019 Jul; 49(7):604-613. PubMed ID: 30927420 [TBL] [Abstract][Full Text] [Related]
40. Risk stratification by somatic mutation burden in Ewing sarcoma. Liu KX; Lamba N; Hwang WL; Niemierko A; DuBois SG; Haas-Kogan DA Cancer; 2019 Apr; 125(8):1357-1364. PubMed ID: 30602061 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]